- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Skin Patch market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.1% during the forecast period.
This report presents the market size and development trends by detailing the Skin Patch market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Skin Patch market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Skin Patch industry and will help you to build a panoramic view of the industrial development.
Skin Patch Market, By Type:
Fentanyl
Nicotine
Clonidine
Buprenorphine
Skin Patch Market, By Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Some of the leading players are as follows:
Sanofi
Teva Pharmaceutical Industries
Bayer
Luye Pharma Group
Novartis AG
Mylan N.V.
GSK
Mylan NV
Johnson & Johnson
Teikoku Seiyaku
Hisamitsu Pharmaceutical
Lingrui
Mundipharma International
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Skin Patch Market: Technology Type Analysis
-
4.1 Skin Patch Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Skin Patch Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Fentanyl
4.3.2 Nicotine
4.3.3 Clonidine
4.3.4 Buprenorphine
5 Skin Patch Market: Product Analysis
-
5.1 Skin Patch Product Market Share Analysis, 2018 & 2026
-
5.2 Skin Patch Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Skin Patch Market: Application Analysis
-
6.1 Skin Patch Application Market Share Analysis, 2018 & 2026
-
6.2 Skin Patch Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
6.3.3 Online Pharmacies
7 Skin Patch Market: Regional Analysis
-
7.1 Skin Patch Regional Market Share Analysis, 2018 & 2026
-
7.2 Skin Patch Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Sanofi
9.1.1 Sanofi Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Teva Pharmaceutical Industries
9.2.1 Teva Pharmaceutical Industries Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Bayer
9.3.1 Bayer Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Luye Pharma Group
9.4.1 Luye Pharma Group Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Novartis AG
9.5.1 Novartis AG Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Mylan N.V.
9.6.1 Mylan N.V. Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 GSK
9.7.1 GSK Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Mylan NV
9.8.1 Mylan NV Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Johnson & Johnson
9.9.1 Johnson & Johnson Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Teikoku Seiyaku
9.10.1 Teikoku Seiyaku Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Hisamitsu Pharmaceutical
9.11.1 Hisamitsu Pharmaceutical Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Lingrui
9.12.1 Lingrui Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Mundipharma International
9.13.1 Mundipharma International Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
The List of Tables and Figures (Totals 90 Figures and 156 Tables)
Figure Fentanyl Skin Patch market, 2015 - 2026 (USD Million)
Figure Nicotine Skin Patch market, 2015 - 2026 (USD Million)
Figure Clonidine Skin Patch market, 2015 - 2026 (USD Million)
Figure Buprenorphine Skin Patch market, 2015 - 2026 (USD Million)
Figure Hospital Pharmacies market, 2015 - 2026 (USD Million)
Figure Retail Pharmacies market, 2015 - 2026 (USD Million)
Figure Online Pharmacies market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Skin Patch market, by country, 2015 - 2026 (USD Million)
-
Table North America Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table North America Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table North America Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table Canada Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table Canada Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Europe Skin Patch market, by country, 2015 - 2026 (USD Million)
-
Table Europe Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table Europe Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table Europe Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table Germany Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table Germany Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table France Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table France Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table Italy Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table Italy Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table Spain Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table Spain Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Skin Patch market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table China Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table China Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table Japan Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table Japan Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table India Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table India Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Skin Patch market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table MEA Skin Patch market, by country, 2015 - 2026 (USD Million)
-
Table MEA Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table MEA Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table MEA Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Skin Patch market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Skin Patch market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Skin Patch market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teva Pharmaceutical Industries Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Luye Pharma Group Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mylan N.V. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GSK Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mylan NV Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teikoku Seiyaku Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hisamitsu Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lingrui Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mundipharma International Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-

Chinese